News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Sponsor & Foundation News

Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study

NeuroDerm Presents Six Posters at the 21st International Congress of Parkinsonís Disease and Movement Disorders

Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinsonís Patients

Survey Examines Social Support in Parkinsonís Disease from the Patientís Perspective

UCB Adds Website for its Facebook-based Parkinson's Community

Acorda Expands Alexa Skill Offering for Parkinsonís Awareness Month

Acorda Announces Long-Term Safety Data for CVT-301

FDA Approves Xadago to Treat Parkinsonís Disease

US WorldMeds is Funding Clinical Trial Studying Effectiveness of New Infusion Therapy to Help Smooth Out Movement for Patients with PD

Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301

LSVT BIG Seminar on Sunday, February 5, 2017 in West Orange, NJ

The Parkinsonís Institute and Clinical Center Awarded $1.9 Million from California Institute for Regenerative Medicine

CurePSP 2017 Southwest Family Conference to be Held in Phoenix on March 17-18, 2017

Adamas Announces US FDA Acceptance of ADS-5102 New Drug Application for the Treatment of Levodopa-induced Dyskinesia in Patients with PD

Parkinson's Disease Foundation Seeks Proposals for $2.7 Million in Parkinsonís Research Funding

Adamas Pharma Announces Submission of ADS-5102 NDA to US FDA as Dyskinesia Treatment in PD Patients

Survey Examines Patient Perceptions of Cognitive Changes in Parkinsonís Disease

Acordaís CVT-301 for Parkinsonís ĎOffí Periods Shows Promising Results in Preclinical Studies

New Device Helps Boost Movement in Parkinson's Patients

The Michael J. Fox Foundation Expands Fox Trial Finder to Accelerate Research in Atypical Parkinsonism

Michael J. Fox Foundation for Parkinsonís Research and Parkinsonís Action Network Announce Plans for Integration

Survey Examines Patient Perceptions of Nutrition and Diet in Managing the Symptoms of Parkinsonís Disease

APDA Establishes Research Fund in Memory of Joel Gerstel

back to top